跳至主要内容
临床试验/NCT04962438
NCT04962438Unknown不适用

Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年7月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Time ending

研究概览

简要总结

Explore the effects of anti-VEGF targeted drugs on blood pressure and endothelial function in cancer patients.

详细描述

Thirty tumor patients with anti-VEGF drugs were selected. Demographic information and clinical information of all patients were collected before chemotherapy. Ambulatory blood pressure monitoring and endothelial function measurement (PWV, EndoPAT) were performed. Ambulatory blood pressure and PWV were reviewed at 2 weeks and 1 month. And EndoPAT, to evaluate the effects of anti-VEGF drugs on blood pressure and endothelial function in cancer patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Tumor patients using anti-VEGF drugs

排除标准

  • Hypertension, coronary heart disease, valvular heart disease, cardiomyopathy and other organic heart diseases, exclude liver and kidney failure, severe cerebrovascular disease, chronic obstructive pulmonary disease, rheumatic immune system disease

研究组 & 干预措施

Tumor patients using anti-VEGF drugs

干预措施: Anti-VEGF (Drug)

结局指标

主要结局

Time ending

时间窗: 1 month

30 days after using the Anti-VEGF Targeted Drugs

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effects of Anti-VEGF Targeted Drugs on Patients'... | 临床试验